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INTRODUCTION 
 
Virtually every one experiences occasional  headache  at  some time in 
their life. WHO ranks headache as one of the top ten disabling   disorder  for 
the two genders & the  fifth most disabling disorder for women.(1) 
Ancient humans have experienced headaches and evidence of remedies 
torelieve  headache.   Pain  can be traced back  as early as 7000BC.  In 1200C 
BEbers Papyrus outlines  a ritual for relieving head  ache. The Egyptians also 
attributed the cause of headache as the work of an evil spirit for  those 
experiencingwarmth in the head, the application of moistened   mortar to the 
head was suggested. The Greeks were the next to espouse willow bark as a 
treatment forpain. Hippocrates (4th or 5th century BC) recommended the 
extract of willow bark for headache  pain. 
 It is estimated that  Globally the percentage of adult population   with 
active headache disorder  are46% for headache in general  11% for 
migraine,42% for  tension type headache &3% for chronic daily   headache1  
Prevalence of headache in India is  63.9 %  with female preponderance.  
In 1992 epidemological studies by Richard Lipton, Walter, Stewart, and 
their colleagues have tremendously expanded our understanding of headaches 
and the recognition of the impact on patients’ lives and society in general. 
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The American Migraine Prevalence and Prevention (AMPP) study  
(AMPP 2004-2009) has provided many answers about headache patients, 
including their treatments, lives, and problems and continues to offer insight 
into the management of the headache.    
In 2013 2  the International  Headache Society (IHS) updated  its 
classification,as  follows   
Ø Primary Headache disorder  
Ø Secondary Headache disorder. 
 Primary headache are those in which headache  and its associated features 
are the disorder itself, whereas secondary headache  are those caused by 
exogenous disorder.  
Common causes of headache 
Ø Primary type – migraine, tension, cluster, idiopathic, exertional 
Ø Secondary type – systemic infection, head injury, vascular disorder, 
subarachnoid hemorrhage, brain tumor. 
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MIGRAINE 
Migraine is the most commonly encountered primary headache 
condition in practice. It is a headache plus syndrome with numerous other 
accompaniments and associations. The term migraine is derived from the 
Greek word Hemi&kranion.  
EPIDEMIOLOGY 
WHO ranks migraine as one of the top 20 leading neurological causes 
ofdisability. It is estimated that 12% of world’s population suffer from 
migraineand in India, of 1200 million population there are 150-200 million 
migraineurs under treatment. The prevalence of migraine is about 20% in 
female and 6% in males4 More common in females than males in the ratio of 
3:1. Three-fourth of Adult migraine patients are females5. Studies have shown 
that women are more likely to have migraine without Aura with peak 
incidence in third decade6 
 A study from a headache clinic (Ravishankar K 1997)(7) has shown 
theprevalence as out of  1000 patients analyzed in the study ,  86% had 
primary headache  and   55%  of these patients who had primary headache,  
had migraine that fulfilled the IHS  criteria. 
National statistics reveal that 31% of migraineurs lose at least one day 
ofwork and 76% lose at least one day of house hold activities every three 
4 
months.51% report that work or school productivity is reduced by half and 
maydecrease even more as the pain intensifies 
HISTORY 
Hippocrates in around 400B.C stated that visual disturbances  can 
precede a migraine such as flashing   light   or blurred vision. Aretaeus of 
Cappodocia (AD 81_138) was the first todistinguish migrainefrom general 
headache, noting migraine’s unilaterality8, periodicity, and the associated 
symptom of nausea. Aretaeus divided all diseases into acute and chronic. For 
headache, he described headaches of short duration, lasting a few days, as 
cephalalgia. The term “cephalea” referred to headaches which lasted longer. 
Because of migraine’s one-sided occurrence, Aretaeus named it Heterocrania, 
meaning “half-a-head.”  
         During the 2nd century AD, Galen (131_201)was credited with 
describing migraine  as  Hemicrania,9and explained  that counter-irritation  as 
a   treatment  for headache,   when he proposed  the use of the electric torpedo 
fish  applied  to the   forehead. This form of therapy foreshadowed the use of 
Electrotherapy by Duchenne (1806_1875) and the transcutaneous electric 
stimulator (TENS) introduced in the late 20th century for all types of chronic 
pain. 
 The use of trephination for headache treatment was described by Paul 
of Aegina(625_690) who practiced in ancient Alexandria. The procedure 
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involved removing a circular portion of the skull, was believed to disturb the 
evil spirits which werecausing the headache pain and allow them to escape 
through the wound. 
Avicenna(980-1037) noted that headache location could vary between 
frontal,occipital, or generalized, and that one-sided headaches could be 
provoked by smells. He used cashews as a remedy for headache as well 
asother neurological and psychiatric disorders. 
 Abulcasis(935-1013) recommended therapy for headache was extreme,  
applying a hot iron to the head of the individual with headaches. Another 
headache intervention that he suggested was an incision made to the temple 
and application of garlic to the wound.   
 Maimonides (1135- 1204) recognized various triggers of headache, 
including extremes of cold and heat, caused bychanges in barometric pressure. 
For headache treatment, Maimonides recommended that those suffering from 
a “strong midline headache, secondary to thick blood or internal coldness” 
couldbenefit from consumption of undiluted wine eitherduring or after a meal. 
The warming effect of thewine would help, and also would thin the blood. 
The monograph Hemicrania was written by CharlesLepois 
(1563_1633).  This work focuses on the author’sown headaches, which were 
only relieved by sleep orvomiting. He found relief with consumption of large 
amounts of fluids. In this treatise, Lepois notes that his headaches are triggered 
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by changes in weather.  He also described an association between one-sided 
headaches and epilepsy. 
DEFINITION: 
Migraine is defined as a complex neurological disorder that 
ischaracterized by recurrent episodes of head pain, autonomic, neurological 
andgastrointestinal symptoms. Migraine attacks typically last between 4 and 
72 hours with freedom from pain between attacks.  
CLASSIFICATION OF MIGRAINE 
I. Common Varieties  
 Migraine without Aura 
 Migraine with Aura 
 Childhood Migraine  
II. Uncommon Varieties  
 Basilar type Migraine  
 Familial Hemiplegic Migraine  
 Migrainous infarction 
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II. According to International Headache Society (IHS 2013)(2),migraine 
is classified  as 
Ø headache with aura 
Ø headache without aura.  
Migraine sufferers experience considerable disability and have 
areduced quality of life, which over the years can affect their work, family 
lifeand routine life style. Attacks cause severe impairment requiring rest in 53 
%of sufferers. 
             Migraine affects the individual’s quality of life and develops a 
significant burden on the society. The economic burden can be direct or 
indirect .Direct cost is the treatment cost while indirect cost is due to the loss 
of productivity and absenteeism. The extent of disability is measured in terms 
of days lost from the school, office work and household work. 
PRECIPITATING FACTORS 
1. Emotional stress 
2. Too much or too little sleep, 
3. Menstruation,  
 4. Alcohol remains a common trigger of migraine 
5. Chocolates 
6. Missing or delaying a meal  
8 
7. Food that contain tyramine can trigger attacks in predisposed 
patients.(hard cheeses, vinegar, yogurt, or any product that 
ishighly fermented) 
8. Chocolates 
9. Odors, particularly pungent ones 
10. Bright light and exercise 
SYMPTOMS OF MIGRAINE:  
 1)  Hypersensitivity to sound 
 2)  Hypersensitivity to light 
 3)  Nausea sensation and vomiting 
 4)  Eyes become red and patient perceives of burning eyes 
 5)  Loss of appetite  
 6)  Throbbing pain in half of head 
 7)  Patient wishes to stays all alone and feels comfortable in silent 
  and dark room. 
  8)  Depression and irritability, numbness or weakness in an arm or 
  leg. 
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TABLE: - 1 DIAGNOSTIC CRITERIA 
 According to the International-Headache-Classification--ICHD-III-
2013(2)-Beta, the following table shows the diagnostic criteria for migraine 
with and without aura. 
MIGRAINE WITHOUT AURA 
DIAGNOSTIC CRITERIA 
A. At least five attacks fulfilling criteria 
B_D                           
B. Headache attacks lasting 4_72 hours 
(untreated or unsuccessfully treated) 
C. Headache has at least two of the 
following four characteristics: 
1. Unilateral location 
2. Pulsating quality 
3. Moderate or severe pain intensity 
4. Aggravation by or causing avoidance 
of routine 
physical activity (e.g., walking or 
climbing stairs) 
D. During the headache, at least one of 
the following: 
MIGRAINE WITH AURA 
DIAGNOSTIC CRITERIA 
A. At least two attacks fulfilling criteria 
B and C 
B. One or more of the following fully 
reversible aura 
symptoms: 
1. Visual 
2. Sensory 
3. Speech and or language 
4. Motor 
5. Brainstem 
6. Retinal 
C. At least two of the following four 
characteristics: 
1. At least one aura symptom spreads 
graduallyover at least 5 minutes, and/or 
two or more 
10 
1. Nausea and/or vomiting 
2. Photophobia and phonophobia 
E. Not better accounted for by another 
ICHD-III diagnosis 
 
symptoms occur in succession 
2. Each individual aura symptom lasts 
5  to 60 minutes 
3. At least one aura symptom is 
unilateral 
4. The aura is accompanied, or followed 
within 60 minutes, by headache 
D. Not better accounted for by another 
ICHD-IIIdiagnosis, and transient 
ischemic attack has been excluded 
 
PATHOPHYSIOLOGY 
Headache is caused by irritation of pain sensitive Intracranial structures 
like dural sinuses, intracranial portions of Trigeminal, Vagus, 
Glossopharyngeal, and upper cervical nerves, large vessels and venous 
sinuses. The structures which are insensitive to pain are Brain parenchyma, 
Ependymal lining of ventricles and the Choroid plexus10. Painful stimuli 
arising from the brain tissue above the tentorium cerebelli are transmitted via 
trigeminal nerve whereas impulses from posterior fossa are conveyed by 
Glossopharyngeal, vagus and upper two cervical nerves10. 
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The key structures involved in primary headache appears to be 
1.  The large intracranial vessels and duramater. 
2.  The peripheral terminals of the trigeminal nerve that innervate 
thesestructures. 
3.  The caudal portion of the trigeminal nucleus which extends into 
thedorsal horns of the upper cervical spinal cord and receives 
input fromthe first and the second cervical nerve roots 
(trigemino cervical complex). 
4.  The pain modulatory systems in the brain that receive input from  
trigeminal nociceptors.11 
PATHOGENESISOF MIGRAINE: 
In migrainepathophysiology neuronal and vascular components are 
very relevant.  The structures which are involved are the brain stem, cerebral 
cortex and the central components of the  trigeminovascular system.  
During a attack of migraine the temporal artery get enlarged and stretch 
the the nerve present   around the artery which release chemicals that cause 
inflammation, pain, and further enlargement of the artery which produces the 
pain. 
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FIGURE:-  1  PATHOGENESIS OF MIGRAINE 
 
Sympathetic nervous system gets activated in patients with migraine. 
The sympathetic nervous systemwhich is a part of autonomic nervous system 
that is responsible for control of stress and pain. Nausea, vomiting and 
diarrhea occurs because of the increased sympathetic activity. It also delays 
stomach emptying and thereby prevents oral medications from entering the 
intestine and being absorbed. The impaired absorption of oral medications is a 
common reason for the ineffectiveness of medications taken to treat migraine 
headaches. The increased sympathetic activity also contributes to the 
sensitivity to light and sound sensitivity as well as blurred vision 
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Cortical spreading Depression: 
 It is a complex phenomenon. Where neurons are generally involved, 
astrocytes may play an important role. Astrocytes regulate the extracellular 
environment, normalizing regions of low magnesium or regions of abnormal 
quantities of glutamate and potassium. Therefore, astrocytic dysfunction can 
lead to regions of the brain being more hyperexcitable than usual. Changes in 
bloodflow that are seen in aura may also be seen in migraine without aura, and 
why the changes that occur during aura are often far more extensive than the 
clinical manifestations of the aura. During CSD there is an increase in 
intracellular calcium, and glial cells communicate via calcium waves, probably 
causing a phenomenon similar to that seen in neuronal CSD. 
 One form of  hemiplegic migraine involves abnormalitiesthat are only 
expressed in astrocytes, and it is likelythat a great deal of migraine pathology 
is astrocytic rather than neuronal. However, the fundamental  hyperexcitability 
of the   cerebral cortex of migraineurs can be documented  with a variety of 
studies 
         Migraine pain may be due to activation of the trigeminovascular   pain 
pathway. This is comprised of trigeminal sensory afferent neurons that 
innervate cranial tissues, in particular the large cerebral arteries andthe 
meninges. It is suggested that the neuronal influence leads to alterations in 
blood flow. Most of these blood flow changes described in migraine are 
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probably secondary to many of the   functional events that occur during a 
attack of migraine.  
It is likely that ‘cortical spreading depression’ is associated with the 
release of a variety of chemicals in the meninges, which activates cranial 
meningeal nociceptors of first-order trigeminal neurons. The subsequent 
pulsatile nature of the headachemay be due to activated trigeminal nociceptors 
on extracranial   arteries, or perhaps these activated trigeminal nociceptors in 
the meninges are reacting tonormal CSF pulsations which would otherwise be 
insensate. This meningeal activation also leads to meningeal inflammation, 
which includes duralplasma protein extravasation and a sterile meningeal 
inflammatoryresponse.  
The symptoms of a severe migraineattack are strikingly similar to the 
symptoms of an attack of meningitis, and this is understandable giventhe 
similarity of meningeal inflammation of migraineand meningeal inflammation 
of meningitis.  
Indeed, in both cases sufferers complain of a pulsatile headache, 
nausea, photophobia, neck stiffness, and pain uponeye movements. 
Vasodilatation alone will not account for the pain of migraine. Vasoactive 
intestinal peptide is a neurotransmitter involved in parasympathetic 
activation,but is not a trigger of a migraine attack, blood flow changes 
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observed in migraine are likelyreflections of the metabolic changes that are a 
consequenceof this cortical activation. 
                   In a migraine attack, there is an initial hyperemia of the brain, 
which is then followed by a prolonged period of oligemia. Calcitonin gene-
related peptide (CGRP) is widely expressed in multiple cell types, and 
certainly throughout the central and peripheral nervous system. Likelymost 
relevant to migraine is its abundance in sensory nerve terminals of 
intracerebral and extracranial blood vessels. With trigeminal nerve activation 
there is an antidromic release of CGRP. When CGRP was infused 
intomigraineurs, it produced a migraine-like headache Nitric oxide (NO) is 
also involved in migrainepathogenesis. Glyceryltrinitrate infusions reliably 
trigger migraine attacks. 
Genetic factors; 
 Familial factors are believed to play an important part in migraine and 
genetic studies have constituted significantly. Migraine is known to be 50% 
more common among first degree relatives of sufferers than in matched 
controls12. Higher rate of concordance for monozygotic twins than dizygotic 
twins & this effect is more in females than males5. Migraine is clearly 
genetically complex with a non-mendelian mode of inheritance and 
mutationlikely in multiple genetic loci. In migraine patients the cause for 
neurologic symptom is mainly   due to mutation in a Brain calcium- channel 
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gene.It was found that in brain and in inner ear a defective calcium channel 
will lead to reversible hair cell depolarization and auditory and vestibular 
symptoms. 
 By studying families with familial Hemiplegic Migraine (FHM) 
migraine genes was identified. Studies also showed that Familial Hemiplegic 
migraine revealed involvement of ion channels & when there is alteration in 
membrane excitability it predisposes to migraine.  
  FHM 1 is caused by mutation that involves the cav2 .1(p/q) type 
voltage gated calcium channel CACNAIA gene will produce FHM 1 (13).  
50% FHM is mainly due to mutation. Mutation in Na+K+ ATPase ATP IA2 
gene, designated FHM2 is responsible for about 20% of FHM.   FHM 311.is 
mainly due to mutation that occurs in the Neuronal voltage gated sodium 
channels SCNIA (Harrison’s17th Edition). 
Evidence from Neurophysiology 
 Trigeminal nerve activities and subsequent changes in the cerebral 
vasculature are widely acknowledged to be key steps in the pathology of an 
attack, associated with a neurogenic inflammation with release of ‘calcitonin-
gene related peptide (CGRP)’, Neurokinis A’ & 5 HT. These substances when 
released may cause irritation of trigeminal nerve afferents. The role of these 
neuropeptides such as CGRP has also been explored14. CGRP is known to be 
released during migraine attacks & CGRP receptor antagonists are under 
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investigation as migraine treatments14. However, it is not only the nociceptive 
afferent pathways that mediate a migraine attack.  
 Disruption of the natural modulation of other sensory pathways by 
cerebral structures is also relevant15. The resultant Sensory sensitivity can take 
many forms. Sensory stimuli may act as Migraine triggers16. Sensory stimuli 
can also execute a migraine attack once initiated, so that the sufferer will show 
behavioural responses in the form of avoidance17. In addition some individuals 
describe symptoms such as photophohia. Exacerbation of head ache by light 
can occur in individuals suffering with migraine who have preserved non-
image forming visual pathways but not in those with no optic nerves or eyes. 
Presence of migraine photophobia was associated with the presence of 
cicardian light induced rhythms. In an animal study it was found that thalamic 
processing of nociceptive and other inputs have a role in mediating migrainous 
symptoms.  
 Role of thalamus comes from recent work identifying third-order 
thalamic neurons as a possible site of action for CGRP receptors. Antagonist 
administration caused reduction in spontaneous firing rate of cells in the 
ventropostero medial nucleus of the thalamus18. Hyper excitability is mainly in 
the sensory system.  
 
 
18 
Evidence from Channelopathies: 
 Ion channel function is critical in the regulation of tissue excitability. 
Channelopathies are a group of disorders that have been shown to be caused 
by ion channel dysfunction19. The group includes for example, hypo & 
hyperkalaemic periodic paralysis and also the various forms of episodic ataxia. 
Migraine shares several clinical features with known channelopathies such as 
an episodic nature with characteristic triggers. Additionally many 
channelopathies exhibit migraine attacks as a part of the phenotype. Examples 
include episodic ataxia type II20& the CADASIL syndrome. These are part of 
a group of single gene disorder for which pathogenic genetic mutation are 
known, that they have a strong association with migraine.  
Evidence from Imaging:  
 Models of migraine pathophysiology acknowledge that the brainstem 
plays an important key role in the genesis of migraine. Chronic migraine is 
due to rostral brainstem vascular malformation14. Brainstem activation has 
been shown on PET scanning in typical spontaneous & induced Migraine 
without Aura22. Furthermore the activated brainstem areas encroach upon the 
location of the vestibular nuclei as identified in previous lesion-based 
structural Magnetic resonance imaging (MRI / Studies)23 
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NEUROTRANSMITTERS: 
Role of Serotonin 
 It has been found that neurotransmitter serotonin plays an important 
role in migraine. In the brain, serotonin normally regulates the vascular 
smooth muscle tone of meningeal blood vessels24. It has been found that a 
relative deficiency of serotonin may constitute to the development of 
migraine25. Tryptans are designed to selectively stimulate sub population of 5 
HT receptors. Tryptans are agonists of 5 HTIB, 5 HTID & 5 HTIF receptors11. 
Role of Dopamine 
 Dopaminergic stimulation produces migraine symptoms.  There is 
dopamine receptor hypersensitivity in migraineurs which is demonstrated by 
giving dopaminergic agonist at doses that do not affect normal subjects. 
Dopamine receptor antagonists are effectivetherapeutic agents in migraine. 
DIAGNOSIS: 
The pain of migraine is commonly unilateral, but can be bilateral. In 
children, it is usually bilateral.Although the quality of pain is often pulsatile, it 
maybe pressure-like or stabbing, even in cases where it is initially pulsatile. 
Light and sound sensitivity ensues, there may be intolerance to light and 
sound, or these stimuli might amplify the pain of the attack. A characteristic 
feature of a migraine is that it worsens with movement. All of these factors 
shape the behavior of migraineurs during an attack. If permitted, they often 
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preferto lie in bed on a few pillows and remain still in a quiet, dark, cool 
environment10. 
Despite the high prevalence of migraine the diagnosis rate remains 
unclear. Neuroimaging studies have found that the hypothalamus is activated 
early in a migraine attack during the prodrome. Therefore, the hypothalamus 
may very well supplant the dorsalpons as the “migraine generator.” Other 
imaging studies suggest differences in grey and white matter, cortical 
thickness, and functional connectivity between the brains of migraineurs and 
controls. It is unclear if many of these changes occur as a direct resultof 
migraine attacks or whether these changes precedethe onset of migraine and 
simply predispose to it. Thus neuroimaging tests  such as  MRI,  PET  
scanning are not necessary to diagnose migraine, but may be used to find other 
causes of headaches in those whose examination and history do not confirm a 
migraine diagnosis.It is believed that a substantial number of people with the 
condition remain undiagnosed. 
Studies have shown that migraineurs are characterized by changes in the 
evoked potentials during headache period.  During the past 30 years, evoked 
potential have been intensely studied in migraine patients. The methods of 
electro neurophysiology are particularly appropriate for the study of migraine 
pathophysiology because they are atraumatic and able to detect functional 
abnormalities26. 
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FIGURE:- 2 DIAGNOSIS OF MIGRAINE 
 
 
 
 
 
 
 Primary headache              Secondary headache 
 
 
 
 
 
 
 
 
 
EVOKED POTENTIAL (EP):- 
 
Evoked potentials are one of the common techniques in 
neurophysiology in the past half century 27. EPs are reliable, sensitive, 
objective measures of nervous system function.  They are sensitive enough to 
detect abnormalities even when the physical examination is normal. 
Evoked potentials refer to surface electrical activity recorded from the 
surfaces of the scalp   in response to specific and adequate stimulus. These 
waveforms are maximized by thecomputer to a point where their latency and 
voltage can be measured. 
Patient presenting with 
headache as a symptom 
History to screen for 
comorbidities 
Testing if 
needed 
(BRAINSTEM 
EVOKED 
AUDITORY 
POTENTIAL) 
History to determine key 
characteristics to identify 
headache type(s) 
Physical 
examination 
Treat 
underlying 
condition 
Formulate 
composite 
treatment 
plan 
Screen for 
secondary 
headache 
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MIGRAINE AND EVOKED POTENTIALS 
Brain stem auditory evoked potentials28 
BAEPs are the electrical potentials recorded from the ear and scalp in 
response to brief sound stimulus to assess the conduction of the impulse 
through the auditory pathway up to the midbrain. 
 Principle of Auditory Evoked Potential 30 
 The evoked response Audiometry is based on the principle that the Bio 
Electric Response evoked by a sound stimulus always occurs after the same 
time interval. Auditory stimulus in the form of clicks or pure tune is used to 
assess the AuditoryPathway. When sound wave reaches cochlea, it is 
converted into an electric impulse and then travels from the cochlea to the 
auditory cortex through the following pathway. 
Spiral ganglia in the cochlea 
 
ventral and dorsal cochlear nucleus in the brain stem 
 
superiorolivary complex in mid brain 
 
Lateral Lemniscus in the mid brain 
 
Inferior colliculus in the mid brain 
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Medial Geniculate Body 
 BAEPs appear following transduction of the acoustic stimulus by the 
ear cells create an electrical signal that is carried through the auditory pathway 
to the brain stem and from there to the cerebral cortex. 
 The Auditory evoked transient response can be recorded up to 500 
milliseconds from the time of onset of the sound stimulus. 
 Brain stem auditory evoked potentials 28 
 Auditory evoked potential of the first 10 milliseconds is called early 
phase of transient response or short latency response (SLR)31.when an auditory 
stimulus is given series of potential can be recorded  in the first 10ms 
corresponding to the activation of peripheral, pontomedullary, pontine, and 
midbrain portion of auditory pathways .  Short latency is also known as 
Brainstem Evoked Response Audiometry (BERA) or Brainstem Auditory 
Evoked Potentials (BAEP), since it records the auditory evoked potential 
when the auditory stimulus is traversing through the brainstem region. 
Advantages of BAEP :- 
1) Identification of the site of lesion in retro-cochlear pathologies. 
The retrocochlear pathologies are a big area from the spiral 
ganglion of the cochlear nerve to the midbrain (level of inferior 
colliculus). BAEP test helps to delineate the approximate area in 
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the retro- cochlear pathway here the lesion is present. This helps 
in diagnosing like acoustic neuroma. 
2) Detection of deafness in the difficult –to- test patients like infants 
and mentally retarded or malingering subjects. This test can be 
carried out correctly even in deeply sedated and anaesthetized 
patients. 
3) Objectively in determining the nature of deafness (whether 
sensory or neural) in difficult –to- test patients, especially when 
the patients cannot follow or respond adequately to tests. 
4) Study of central auditory disorders - Evoked response audiometry 
has been found to be of use in separating diseases of the auditory 
cortex from diseases of the more peripheral organs. 
Anatomical and physiological basis of brain stem auditory evoked 
response audiometry32 
The displacement of the tympanic membrane produced by the sound 
pressure wave is transmitted to the oval window through the inner ear ossicles. 
This produces movement of the perilymph and secondarily of the endolymph, 
which is contained in the ductus cochlearis and also includes the basilar 
membrane, spiral organ, and the tectorial membrane. The spiral organ contains 
hair cells that, when displaced by the movement of the tectorial membrane, 
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produces auditory potentials. The receptor potential leads to the release of the 
neurotransmitters, which trigger action potentials in the dendrites of the 
ascending nerve fibers of the cochlear nerve. The basal portion of the basilar 
membrane is activated by high frequency sound whereas sounds of low 
frequency generate receptor potentials in the apical portion of the cochlea. The 
click, which is most commonly used stimulus to produce BAEPs contains 
mainly high –frequency components and therefore mainly activates the basal 
cochlear portion. The cochlear nerve neurons are bipolar, situated in spiral 
ganglia and their dendrites go to hair cells and axons to the cochlear nucleus. 
The cochlear nucleus has three sub- nuclei: 
1. TheAnterior ventral cochlear nucleus (AVCN) 
2. The Posterior ventral cochlear nucleus (PCVN) 
3. The Dorsal cochlear nucleus (DCN) 
  The AVCN output is through the ventral acoustic striae forming the 
bulk of trapezoid body to terminate in the superior olivary nuclei and inferior 
colliculus. The neurons in the AVCN discharge at short latency to acoustic 
stimuli with a pattern like that of eighth nerve.The PVCN output mostly goes 
through ventral and middle acoustic striae to terminate in the superior olivary 
nuclei and inferior colliculus. 
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 Dorsal cochlear nucleus terminates in the superior olivary nucleus and 
contralateral inferior nucleus through dorsal striae. The discharges from these 
neurons are different from AVCN by having a longer latency.  
   Basalportion in pons superior olivary nuclear complex consists of 
medial and lateral components cochlear nucleus terminates in it .The medial 
components receives the input from both ipsilateral and contralateral AVCN 
which are excitatory. The lateral superior olivary nucleus also receives 
ipsilateral excitatory inputs from AVCN and PVCN and inhibitory inputs from 
contralateral AVCN and PVCN via trapezoid body. Olivary nuclei are the first 
site in auditory pathways where neurons are affected in a nonlinear manner to 
binaural stimulation.  
 The inferior colliculi and the lateral lemniscal nuclei converge the input 
from contralateral cochlear nucleus and superior olivary nucleus. From 
inferior colliculi the impulse travels to medial geniculate body and then to 
auditory cortex. Orderly orientation of the neurons in dorsal cochlear, medial 
superior olivary, and lateral superior olivary nuclei results in summation of 
synaptic potentials to result in high amplitude electrical fields. 
 As the auditory impulses traverse through the different stations in the 
auditory pathway, it undergoes some degree of processing at each of the 
stations. Passage of the impulse through this pathway generates an electrical 
activity which can be monitored by placing a surface electrode on the vertex of 
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the scalp. On graphical recording, this electrical activity presents a wave –
form with discrete peaks, the character of which is dependent upon the 
functional and structural integrity of the above mentioned pathways. 
FIGURE:-3Anatomical and physiological basis of brain stem auditory 
evoked response 
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Terminologies used in evoked potential study29 
Hearing level (dB HL) 
This scale refers to the number of decibels of intensity compared to the 
threshold of hearing in a group of normal subjects. Zero on this scale is 
defined as the threshold at which a normal subject can just perceive 50% of 
the stimuli. 
Sensory Level (dB SL) 
On this scale zero is defined as the point at which the individual can 
barely appreciate the stimuli. 
Physical Definition (dB pe SPL) 
Physical measurement of sound pressure levels used at the zero dB 
reference level. There is a pressure of 20uPa which equals 0.002dyn/cm2. The 
zero dB pe SPL turns out to be approximately equal to – 32 dB HL. 22 
Individual Equipment scale 
Individual equipments have their own dial setting in terms of dB, which 
should be correlated with HL or SL. For deciding the click intensity in a 
patient, dB SL is measured and the stimulus delivered 60-70 dB higher. 
Normal BAEP 
Classical BAEP consists of ‘5-8 vertex’ positive peaks which are 
labeled using ‘Roman numbers.’ The first five peaks are of clinical 
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importance. The troughs immediately following the peaks are designated by a 
prime mark eg, the trough of wave I is designated as I’. 
TABLE:-2 Generators of BAEP waveforms 
Wave form Generators 
I Eighth cranial nerve 
II Cochlear nucleus 
III Superior olivary nucleus 
IV Lateral lemniscus 
V Inferior colliculus 
 
FIGURE:-  4 GENERATORS OF BERA 
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Wave formrecognition 
Wave 1 
This is the first prominent up going peak in the ipsilateral ear recording 
channel.  It is reduced or absent from the contralateral ear recording channel. It 
appears 1.4 ms after the stimulus. The amplitude of this wave can be increased 
by using horizontal montage, external canal needle electrode, nasopharyngeal 
electrode, increasing stimulus intensity or decreasing the stimulus rate. 
Patients with central nervous system problems only, should have a preserved 
wave I since it originates from VIII nerve.Conversely, the patients with 
significant peripheral hearing impairment may have a very poorly formed or 
absent wave I but relatively normal wave II-V. 
Wave II 
Wave II is poorly defined in some adults and most neonates. It 
sometimes appears as a small peak following wave I. It may appear in the 
down going slope of wave I or in the up going slope of wave III. It is more 
prominent in contralateral channel recording where it has a slightly prolonged 
latency compared to ipsilateral. Sometimes the fusion of waves II and III 
results in M-shaped II-III complex. 
Wave III 
It has a prominent up going peak. It is smaller and appears earlier in the 
contralateral channel. Some normal subjects have a bifid wave III. Bifid wave 
III may be related to the condensation or rarefaction clicks. 
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Wave IV 
This wave is identified as the peak just preceding the wave V. So once 
wave V is identified, it is not difficult to recognize wave IV. Sometimes the 
wave IV and wave V becomes superimposed leading to difficulties in 
identification of the waves. A distinct and separately identifiable wave IV is 
present in only 50-60% of subjects. In other cases the wave IV cannot be 
identified separately. 
Wave V 
It is the most reliable and easily identifiable wave in the BAEP tracing. 
The hallmark of wave V is that there is a sharp negative (downward) 
deflection immediately following the peak. (The wave V usually appears at 
5.6-5.85 milliseconds in normal subjects when the BAEP test is done at 50-60 
dB suprathreshold level. Though the amplitude of the BAEP waves is variable, 
yet it is usually the target and the most robust of the five BAEP waves) 
Measurement and normal values of BAEPs 
The following variables are studied 
1.  Absolute latency and amplitude 
2.  Inter peak latencies (IPLs) 
3.  Amplitude ratio of wave V/I 
4.  Inter ear inter peak differences 
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Absolute latencies and amplitudes 
Absolute latency is measured as the distance from the beginning of the 
first wave to peak .The amplitude is measured as the height from peak to 
trough of that wave. The difficulty is encountered when the wave forms are 
poorly formed. The recommended method for latency comparison is to 
superimpose the major ascending and descending limbs of waves of two sides 
against a strong source of light.  
Inter peak latency 
The commonest   inter peak latencies employed in clinical practice are 
I-V, I-III, and III-V. 
I - V IPL 
Normal value is 4.5ms. It is a measure of conduction from proximal 
VIII nerve through pons to midbrain. This IPL is slightly shorter in young 
female and longer in older male. Normal right to left asymmetry should not 
exceed 0.5 ms. 
I - III IPL 
Normal value is about 2.5ms.It measures conduction from VIII nerve 
across subarachnoid space into the core of lower pons. The I-III IPL can be 
increased in any diffuse process that affects the generation of these waves.  
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III-V IPL 
The normal value is about 2.4ms. It  measures conduction from lower 
pons to midbrain.  
V/I amplitude ratio 
Since wave I is generated outside and wave V inside, these can be 
compared to determine the relationship of expected amplitude. Wave V/I can 
be expressed either as ratio or percentage. The amplitude ratio is normally 
between 50% and 300%. The amplitude ratio may be influenced by filter 
setting and click intensity, therefore, comparison with the normal values of the 
respective laboratory is essential. When the amplitude ratio V/I is lower than 
50% then  there will be a   small wave V, and may be consistent with a central 
impairment. Very high V/I amplitude ratio (300%) suggests small amplitude 
of wave I, which may be due to peripheral hearing impairment. 
Inter ear latency difference 
The difference in the absolute latency of a particular wave in between 
the two ears should not be more than 0.5 ms, provided the same 
suprathreshold sound stimulus has been presented to the two ears 
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TABLE:-  3  BAEP Normal values 
Wave (latency ms) Chiappa et al (1979) Misra and Kalita 
I 1.7 + 0.15 1.67 + 0.17 
II 2.8 + 0.17 2.78 + 0.21 
III 3.9 + 0.19 3.65 + 0.22 
IV 5.1 + 0.24 5.0 + 0.30 
V 5.7 + 0.25 5.72 + 0.3 
VI 7.3 + 0.29 7.2 + 0.48 
I-III IPL 2.1 + 0.15 1.99 +0.25 
 
Variations inBAEP 
BAEP abnormalities may include the following 
    1.    Absence of wave forms 
    2.  Amplitude ratio abnormalities 
    3. Abnormal absolute or inter peak latencies 
4.  Right to left asymmetry 
 In most normal individuals waves I-V are seen. Sometimes in normal 
subjects, wave IV may form a wave IV-V complex. In such a situation, if there 
is absence of wave IV it does not indicate an abnormality.It is also difficult to 
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distinguish wave II in some normal subjects.  When all the waves are absent, it 
is (I-V) is abnormal. When wave I is recordable and not the succeeding waves, 
it is abnormal. Similarly recordable wave I and III but unrecordable wave IV 
and V is also abnormal. 
Factors affecting BERA recording 
Technical factors 
Stimulus rate 
This is the number of clicks presented to the ear per second. The 
recommended rate is 10- 40 clicks per second. Very high stimulus rates such 
as 80 or 100 clicks per second change the latency and amplitude of the BERA 
waves. Usually, the amplitude decreases and the latency increase if the 
stimulus rate is high. 
Stimulus phase or polarity 
The phase of the click stimulus may be two types, viz. condensation 
phase and rarefaction phase. The transducer which produces the click sound 
has a diaphragm which vibrates. When the diaphragm moves towards the ear 
drum, the phase is called condensation phase. When the diaphragm moves 
away from the ear drum, it is called rarefaction phase. For routine BAEP 
studies, use of rarefaction phase is recommended, mainly because it produces 
better resolution of the BAEP waves. However, the latency and amplitude of 
wave V is not much altered by the phase of sound stimulus. 
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Intensity of the sound stimulus 
For routine BAEP studies, the intensity of the click stimulus of 60 dB 
suprathreshold is recommended i.e. 60dB above the hearing threshold of the 
ear being tested.on lowering the intensity of the click stimulus there is an 
increase in the absolute latencies and there is a decreases in the amplitude of 
the BAEP waves. Since the amplitude and latency of the BAEPwaves are 
dependent upon the intensity of the click sound used, same intensity should be 
used not only in both the ears of the same patient but also in all patients such 
that the results are easily comparable. 
Binaural / Monaural stimulation 
In clinical studies only a monaural stimulation is recommended, i.e. one 
ear at a time should be tested. Presenting stimulus to both ears together 
increases the amplitude of the wave III, IV, V but not wave I. 
Filter characters of the machine 
The BAEP machine should be so adjusted that it records only between 
a fixed ranges of frequencies. The lower limit of this frequency range, called 
low frequency filter should be 100Hz or 150 Hz and the higher frequency 
filter is usually kept at either 3000 or 5000 Hz. To interpret the 
BAEPaccurately and to compare it with the normative data, fixed or standard 
and correct filter settings should be used. Altering the filter settings will 
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change the amplitude ratios of the waves and introduce unwanted artifacts into 
the BAEP tracing. 
Nature of the sound used 
The sound stimulus used is a click sound. The click sounds are 
generated as square wave pulses each of which are of 0.1 millisecond duration. 
When BAEP test is being done for neurological diagnosis, it is essential that 
all the BAEP waves are clearly recorded. Hence sound stimuli (clicks only) 
are delivered at 50-60 dB above hearing threshold since this evokes neat and 
robust easily recognizable wave peaks. 
Confounding variables 
Age 
Interpeak latency (IPL) I-V is slightly longer by 0.1-0.15 ms in older 
individual compared to younger individuals35 
Gender 
Womens have a shorter latency and higher amplitude of BAEP .The I-
V interpeak latency  is shorter by 0.1 ms in females when  compared to 
males.35 
Temperature 
The absolute latency and IPL are prolonged on lowering the body 
temperature. A 0.17 ms increase in wave V latency on 1 degree Celsius 
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reduction of body temperature has been reported. At 32.5 degree Celsius 
BAEP waves are distinctly abnormal and at 27 degree Celsius the wave forms 
disappear36. 
Among all the evoked potentials, BAEP’s  is commonly used because it 
is a  more reliable electrophysiological method and  it is a non-invasive  
procedure to evaluate the function of brainstem structures which is travested 
by acoustic pathways. Assesment of the acoustic pathway by BAEP’s which 
plays a very important role in the description of pathophysiology of primary 
headache especially migraine. This study was done to evaluate the 
involvement of Brain stem structures in migraine patients. 
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REVIEW OF LITERATURE 
 
MIGRAINE  
 One of the oldest ailments known to mankind.is migraine. In around 
400B.C Hippocrates stated that migraine is preceded by visual disturbances 
which we call aura. Aretaeus was credited for his migraine discovery who 
described one sided headache later it was Galenus who pointed connection 
between stomach and brain due to vomiting 
 Abu Bakr Mohamed pointed association between Migraine and 
Hormones. `In 1950 Harold Wolff proposed that blood vessel   abnormalities 
were associated with migraine. Migraine has a great impact on physical, 
mental, functional &socioeconomic aspects of patient’s life37. Migraineurs 
have higher life time risk of Panic disorder depressive disorder, generalized 
anxiety disorder, phobia and suicide attempts than the normal subjects.38If  
migraine is diagnosed the next important step is to evaluate theextent of the  
patient disease and disability. 
The migraine disability assessments say (MIDAS Questionnaire) by 
Innovative Medical Research 1997 is used validated easy to use tool. Patients 
were asked to answer questions, & accordingly they are divided into 4 grades.  
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Grade 1- Minimal or infrequent Disability; 0-5 
Grade II –Mild or infrequent Disability; 6-10 
Grade III- Moderate Disability: 11-20 
Grade IV-Severe Disability :> 20 
CONFOUNDING VARIABLES AND MIGRAINE 
 In a study done by Stewart et al 4 a mailed survey was done to 
evaluate the age and sexspecific incidence in 120000 US subjects.  The 
incidence of migraine is maximum in the ages of 20 and 24 in women and 
ages 15&19 in males. Migraine is highly prevalent in the population, with the 
cumulative prevalence being 43% in femalesand 18% in males. In young 
children migraine ismore prevalent in males, but by puberty females 
predominate. 
Rasmussen BK, Olen6  conducted studies by randomly selecting  3000 
males and 1000 females aged 40 years from Danish population by mailed 
questionnaire regarding migraine and it was found  that the  prevalence of any 
type of migraine  was 18%.  Out of these, 12% are male & 24% are females.  
The male female ratio is approximately 1:2 & has shown that females are 
more likely to have migraine without aura with peak incidence in third decade   
Bigal et al39 in his study has stated that obesity has been recognized to 
be a significant risk factor for the transformation of episodic attacks into a 
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chronic form of migraine Higher BMIs will increase the risk of all chronic 
headaches, and they are positively correlated with headache frequencyand 
disability.When overweight subjects subsequentlyreduce their BMI, it often 
leads to a reduction in headache frequency. Bariatric surgery for those who are 
morbidly obese is often recommended. 
COMPLICATION: 
Peatfield et al. 198140 stated  that the migrainous aura is visual in 82% 
Rasmussen and Olesen, 19926 found that the migrainous aura is visual in  
90% of cases, and  it was also found that hypersensitivity to light is mostly 
present in migraine attacks . People who get migraines often describe the pain   
as one sided pain severe headache disorder. During migraine attack, the patient 
becomes very sensitive to light and sound.  
Thaker et al41 studied the association of migraine with vertigo and it 
was found that out of 344 cases of vertigo, 19 had headache characteristic of 
migraine. The spectrum ranges from a transient reversible dysfunction to a 
more permanent destruction and includes involvement of both peripheral and 
central vestibular system. 
Parker42-reported that there is a strong association between migraine 
and vertigo results of his study showed reversible hair cell depolarization 
leading to auditory and vestibular symptoms is due to the defective calcium 
channels, primarily expressed in brain and inner ear.. 
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 Laila E Mosley38 stated that migraineurs have higher life time risk of 
Panic disorder depressive disorder, generalized Anxiety disorder, phobia and 
suicide attempt than the normal subjects. Nofal found that migraine has a great 
impact on physical, mental, functional & socioeconomic aspects of patient’s 
life.  
PATHOGENESIS OF MIGRAINE- 
 Bhowmik et al43 found that certain triggering factors such a missing 
ameal, hypoglycemia, increased tension,  lack of sleep , menstruation,  
hormones,  or   smoking, alcohol etc causes vascular disturbance. A vascular 
disturbance is thought to cause migraine. 
 Golla and Winter described a particular response of migraine patients 
to light stimulation. This consisted of the exaggeration of the response itself to 
a wider range of stimulus frequencies, in comparison with normal subjects. 
Certain factors can trigger migraine in persons who are prone to develop 
headaches called migraine triggerers 
 On the onset of menstruation the blood estrogen level decreases in 
some woman which is a trigger for migraine attack. On fasting there is 
hypoglycaemia which precipitates migraine attack. Therefore, prolonged 
fasting should be avoided by migraine sufferers. 
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 Kelman 2007: Martin et al 200644 Sensory stimuli may act as 
Migraine triggers Sensory stimuli can also execute a migraine attack once 
initiated, so that the sufferer will show behavioural responses in the form of 
avoidance 
Noseda et al 201017 In addition some individuals describe symptoms 
such as photophohia. Exacerbation of head ache by light can occur in 
individuals suffering with migraine who have preserved non-image forming 
visual pathways but not in these with no optic nerves or eyes. Presence of 
migraine photophobia was associated with the presence of cicardian light 
induced rhythms. In an animal study it was found that Thalamic processing of 
nociceptive and other inputs have a role in mediating migrainous symptoms. 
Coleston199445 suggested that in migraineurs the abnormalities 
reported reflect dysfunctions at the cortical level, but precortical visual 
processing may also be impaired  
(LipkinAF, Jenkins HA)31 & (VIERRE et all 1996) observed  that    
woman developed recurrent episodes of sudden sensorineural hearing loss, 
occurring with migraine headaches and found out that  it is an unusual 
complication of migraine, which probably arises from a reversible 
vasoconstriction of the cochlear blood vessels. Spasm of the cochlear vessels 
is responsible for reversible hypoxic injury and temporary hearing loss. 
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 Ambrosini. A et al. 200326 said that in migraine patients the cereberal 
cortex has a reduced preactivation excitability level thus causing habituation 
deficit 
 Summ et al 201046 Role of Thalamus comes from recent work 
identifying third-order thalamic neurons as a most important site for CGRP 
receptors. Antagonist administration caused reduction in spontaneous firing 
rate of cells in the ventropostero medial nucleus of the thalamus.          
Lance et al obtained circulatory alterations in migraine by stimulating 
locus coeruleus in cats and monkeys. Based on this other authors studied 
brainstem function by means of a technique called BERA experience to have 
migraine without aura with peak incidence in third decade. 
Robert W. Baloh MD, 199747 suggested that reversible hair cell 
depolarization with auditory   and vestibular symptom is due to the defect in 
calcium channels present in brain and inner ear.In families with migraine 
headaches and neurologic symptoms this hypothesis is under investigation. 
 Iadecola – 2002 proposed that Trigeminal nerve activities and 
subsequent changes in the cerebral vasculature are widely acknowledged to be 
key steps in the pathology of an attack, associated with a neurogenic 
inflammation with releasing a large amount of ‘calcitonin-gene related peptide 
(CGRP), Neurokinis- A & 5 HT. These substances when released may cause 
irritation of Trigeminal nerve afferents. 
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Goadshy et al 200921 The role of these Neuropeptides such as CGRP 
has also been explored. CGRP is known to be released during migraine 
attacks. Godsky 2008 CGRP receptor antagonists are under investigation as 
migraine treatments.  Nociceptive afferent pathways mediate a migraine 
attack.  
Goadshy & Holland 200915 Disruption of the natural modulation of 
other sensory pathways by cerebral structures is also relevant. The resultant 
sensory sensitivity can take many forms. 
BAEP IN MIGRAINE- 
Stockard et al. 197135, Allison et al. 1983 suggested that women have 
a higher amplitude shorter latency of BAEP. The I-V IPL is shorter by 0.1 ms 
in female compared to male. 
Laila EL Moslyet al38 evaluated the effect of migraine on quality of 
life in females and associated changes in evoked potentials. They measured 
BAEP in 30 migraine patients and reported that there was prolongation of 
wave III& wave V latency and I- III & I- V interpeak latency due to 
hyperexcitability of the cerebral cortex but no significant change in III – V 
interpeak latency both during an attack and in the interictal phase. In migraine 
patients the abnormalities reflect not only dysfunctions at the cortical level, 
but it is found that precortical visual processing is also impaired. 
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Newer et al. 199449 Studies revealed that there is prolongation of I-V 
interpeak latency in older adults by 0.1-0.15ms. Wanget al 1996 conducted a 
study and observed that in migraine patients there is interictal 
electrophysiological abnormality which is intensity dependent of Auditory 
evoked cortical potential 
 Anil K Dash et al., studied   audiovestibular   functions   in migraine 
patients with and without vertigo. BAEP results revealed that there was 
increase in I, III and V latencies and interpeak latencies I-V, III-V & I-III. This 
study concluded that auditory involvement is the earliest indicator in migraine 
patients and this was found by BAEP abnormalities. 
Dorfman et al (1981)36 found that the absolute latency and IPL are 
prolonged on lowering the body temperature. A 0.17 ms increase in wave V 
latency on 1 degree Celsius reduction of body temperature has been reported. 
At 32.5 degree Celsius BAEP waves are distinctly abnormal and at 27 degree 
Celsius the wave forms disappear 
Kaushal et al52 who evaluated BAEP in 25 migraine patients. The 
results revealed prolongation in latencies   I, III & V latencies and interpeak 
latencies I-III & I- V and it was stated that prolongation was due to 
involvement of Brainstem structures as well as activation of brainstem in 
migraine patients.  
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 The   methods  of  electro neurophysiology  are particularly  
appropriate   for  the  study  of  migraine  pathophysiology  because  is a  more 
reliable method and  it is a non-invasive   procedure to evaluate the function of 
brainstem structures which is travested by auditory pathways. Among all the 
evoked potentials, BAEP  potentials is commonly used because 
neurophysiological examination by means of auditory evoked potential enable 
us to make neurophysiological assesment of the auditory pathway which plays 
a very important role in the description of pathophysiology of primary 
headache especially migraine. 
This study was done to evaluate the involvement of Brain stem 
structures in migraine patients. Review of literature highlights the fact that 
auditory pathway is definitely involved in migraine patho physiology but the 
extent of involvement with concordance evidence of duration was 
inconclusive. So the aim of the present study is to evaluate BAEP in migraine 
patients at the earliest to detect the subclinical involvement of the nervous 
system. 
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AIM AND OBJECTIVES 
 
AIM: 
 “To evaluate the Auditory Brain Stem Evoked Response in Migraine 
Patients and to compare it with normal subjects 
OBJECTIVE;   
1.  To evaluate ‘Auditory Brain Stem Evoked Response’ in migraine patients.  
2. To compare the latency and interpeak latency of BAEP waves between 
migraine and normal subjects. 
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MATERIALS AND METHODOLOGY 
 
Study design: Case control study 
        Control – Normal Subjects 
        Case – Subjects Fulfilling the Criteria Of Migraine As Per International   
Headache Society 
Period of study: 
 One year (2015 to 2016) 
Place of study: 
 Department of PHYSIOLOGY 
Chengalpat Medical College, Chengalpat 
 
Selection of subjects - Sixty subjects participated in the study 
Study group 
 Thirty subjects fulfilling the criteria of migraine as per the HIS 
(International Headache Society)1 from the outpatient department of the 
Institute of Neurology, Chengalpat Medical College, Chengalpat. 
 Age group: 20-50 years of both sexes. 
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Control group 
 Thirty age and gender matched normal subjects were included in the 
study for comparison with the study group. All the participants were informed 
about the study, oral and written consent were obtained. Permission from the 
Institutional ethical committee was also obtained 
Inclusion Criteria for Study Group                           
· Age group 20 to 50 yrs / both gender  
· Migraine With Or Without Aura at least For a Period of 6 Months  
· Patient With Normal Respiratory/Cardiovascular/Hepatic Function 
· Patients with normal hearing and normal vision. 
Inclusion Criteria for Control Group: 
· Age group between 20-50-yrs 
· Subjects with Normal Hearing and Normal Vision 
Exclusion Criteria:    
· Known Hypertensive  
· Diabetes Mellitus  
· Ear Diseases 
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· Anaemia 
· Known Smoker / Alcoholic / Any medication  
· Any Other Neurological Illness 
· Those who are on medications which  affects hearing 
Clinical Examination 
Routine clinical examination was performed. Rinne’s, weber   and pure 
tone audiometry was conducted.  Following that BERA was done byusing 
‘NEUROPERFECT EMG-2000(EMG/NCV/EP’ System. 
FIGURE:-5 ‘NEUROPERFECT EMG-2000(EMG/NCV/EP’ 
System 
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ACCESSORIES  
  
A-GROUND ELECTRODE 
B-RECORDING ELECTRODE 
C-HEAD PHONE 
BAEP 
The apparatus set up for measuring Brainstem Evoked Response 
Audiometry are set up as per the “Recommended standards for the clinical 
practice of Evoked potentials; introduced in Guide line 9A: Guidelines on 
Evoked potential by American Society of Clinical Neurophysiology. 
 
 
A 
B 
C 
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FIGURE:-6 The basic apparatus for recording of auditory 
brainstem evoked responses (ABR) is illustrated 
 
 
  
 
 
 
 
 
 
 
 
1. Pulse generators: 
 Ear phone or head phone has a transducer which transmits the stimulus 
in the form of clicks. 
2.  Recording Electrodes 
The electrodes required for BAEP measurement are placed in the 
corresponding sites of scalp following the international 10-20 Electrode 
placement system. High quality EEG electrodes are used. Both needle and 
surface electrodes can be used for recording BAEPs. Surface electrodes are 
preferred because it is painless and there are lower chances of infection. For 
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better placement of electrodes, oil must not be applied.On the day of 
investigation patient is asked to have a thorough shampoo  bath. 1 cm disc 
electrodes filled with conducting jelly or paste is preferred. The electrical 
impedance should be kept below 5 kilo ohms. If the impedance is too high, the 
skin is cleaned again with acetone and the surface electrode is reapplied 
together with electrolyte jelly or EEG paste. Active and ground electrodes are 
placed on the ipsilateral and contralateral mastoid process respectively (Lau S 
K and William)30after the skin has been cleaned. The electrode on the vertex 
acts as the reference. 
FIGURE:7ELECTRODE PLACEMENT 
 
3.  Filter 
Filter is a device, which selectively restricts the frequency domain of a 
signal. The filter band pass is the frequency range of a signal, which is 
transmitted through the filter. The frequency range in which the signal is 
rejected is known as stop band. Filtering of neurophysiological signals is 
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required for eliminating the noise and optimizing the recording. Filtering is 
also useful for bringing out the characteristics of the waveforms. 
The low frequency filter removes the slowly changing low frequency 
components and allows the higher frequencies to pass through. Therefore, the 
low frequency filter is also known as high pass filter. Similarly, the high 
frequency filter eliminates the rapidly changing high frequency components 
and allows the low frequency components to pass through. Hence the high 
frequency filters are known a low pass filters. 
Filter setting for BERA is as follows 
Low-cut filter: 10- 100 Hz 
High-cut filter: 3000 Hz 
4.  Amplifier 
Since the biological signals are very small (5 to 50 micro volts), 
variable degree of amplification (up to 500,000) is needed equal to the range 
of Analog to Digital converter. The electrode impedance includes intrinsic 
impedance of the electrodes and the impedance of electrode – skin interface. 
For the measurement of any electrical activity say for example, the action 
potential generated in central nervous system, nerve or muscle, must flow 
through the electrode into the amplifier and return to the patient through the 
ground lead. Electrode impedance results in drop of the amplitude of action 
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potential. This attenuated action potential reaches the amplifier. To reduce this 
attenuation, the impedance of the amplifier must be much greater than the 
electrode impedance. According to the recommended standards of the 
Guideline 9 (A) the differential input impedance of the amplifier must be at 
least 100 mega ohms. This minimizes the waveform distortion and improves 
noise rejection. Unequal electrode impedance imbalances the electrode 
amplifier input, converting some of the noise into a differential signal, which 
is amplified to the same extent as the neurophysiological signal. 
5.  Signal averager 
The process of measuring the electrical activity in the brain in response 
to sound stimulus presented to the ear, is a very complicated and cumbersome 
process. This is so because, some degree of random and spontaneous electrical 
activity is continuously occurring within the brain. A recording of this random 
electrical activity is called electroencephalography (EEG). The electrical 
activity set up in the brain, in response to a sound stimulus, mingles up and 
mixes with the random and spontaneous electrical activity occurring within the 
brain and gets obscured. The magnitude of the electrical activity evoked by a 
sound stimulus is only 1/100 of that of spontaneous random electrical activity 
(Background potential). To separate these two types of electrical activity, a 
process called “signal averaging” is done. This is based on the fact that, 
evoked electrical activity is time specific and occurs at a fixed point of time 
after the sound stimulation, whereas, the random electrical activity is not time 
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specific and occurs at random. Hence, if the electrical activity generated by a 
very large number of separate sound stimuli at a specific point of time is added 
together, only the electrical activity evoked by sound stimulus will keep on 
adding, whereas, the background potential occurring at random without any 
time specificity will cancel each other. Thus this signal averaging technique is 
used to clarify and not amplify the responses and enables to get the 
uncontaminated measure of the sound evoked electrical activity. A 10 
millisecond epoch after the stimulus is generally averaged for BAEP studies. 
At least 1000-2000 trials are averaged to get a good quality recording. Two to 
three repetitions are done and superimposed to check for reproducibility. The 
latency values measured in the separate repetitions should agree with each 
other within 0.1millisecond or less. The amplitude values should agree with 
each other within 10%. 
6.  Electrical safety 
In recording BERA, measures must be taken to assure the patients 
safety. The grounding and the chassis leakage current of all instruments 
connected to the patient are located in the same room as the patient must be 
periodically tested. Equipment should be designed to prevent inadvertent 
shock power –on, power –off and failures. 
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Running the test 
 One ear was tested at a time. Other ear was masked with white noise. 
Click stimuli of intensity 70dB above normal hearing threshold, at the rate of 
10sec and 0.1 msec duration were presented monoaurally The other ear was 
masked by White noise-40Db  HL.  
Statistical  analysis: 
 The BAEP  parameters  such as  latency,  and inter peak latency of the 
study group was compared with the control group by using SPSS version 18. 
FIGURE:-8 RECORDING OF BAEP BY USING’ NEUROPERFECT 
EMG-2000(EMG/NCV/EP’  SYSTEM 
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RESULTS 
 
Out of 60 subjects who participated in the study, 30 were control group 
and 30 are migraine subjects. BAEP was done, latency and interpeak latency 
was taken for analysis 
 The data were statistically analyzed and their significance derived using 
independent samples T-Test and paired T-Test. 
P value < 0.05 was considered significant.  
P value <0.01 was considered highly significant. 
P value < 0.001 was considered very highly significant 
TABLE: 4 CONFOUNDING VARIABLE 
PARAMETERS CONTROL MIGRAINE P VALUE 
Age 31.20 ±7.15 34.03 ±10.33 0.222 
Height 157.10 ±5.53 153.67 ± 4.95 0.014 
Weight 57.07 ±6.19 56.57 ± 5.01 0.732 
Gender 1.80 ±0.41 1.93 ±0.25 0.133 
BMI 22.73 ±2.35 23.77 ± 2.57 0.109 
p≤0.05 is significant; p≤0.01 is highly significant; p≤0.001 very highly 
significant. 
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 Table 4. shows no statistically significant difference in both control and 
study groups regarding age distribution, height, weight, gender and body mass 
index. 
TABLE: 5  BAEP LATENCY IN LEFT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
Lat 1 1.35 ± 0.40 2.18 ± 0.23 
Lat 2 2.23 ± 0.56 2.77 ± 0.43 
Lat3 3.09 ± 0.37 4.21 ± 0.29 
Lat4 4.80 ± 0.18 5.22 ± 0.34 
Lat5 5.01 ± 0.31 6.14 ± 0.29 
 
 The mean latency of  BAEP  waves of control group was compared              
with  migraine patients  and it was found to be prolonged. 
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FIGURE 9 SHOWS COMPARISON OF BAEP LATENCY IN 
LEFT EAR 
 
 
 
 The graph shows   mean latency of control and migraine cases.Latency 
is prolonged in  migraine compared to controls 
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TABLE: 6 COMPARISON OF BAEP LATENCY OF THE LEFT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE 
PATIENTS 
n=30 
P VALUE 
Lat 1 1.35 ± 0.40 2.18±0.23 0.000 
Lat 2 2.23± 0.56 2.77±0.43 0.000 
Lat3 3.09± 0.37 4.21±0.29 0.000 
Lat4 4.80± 0.18 5.22±0.34 0.000 
Lat5 5.01±0.31 6.14±0.29 0.000 
 
p≤0.05 is significant; p≤0.01 is highly significant; p≤0.001 very highly 
significant. 
 
 This tables shows prolongation of latency of BAEP of left ear of 
migraine patients compared to control group and this is statisticaly significant.
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Table: 7 INTER PEAK LATENCY IN LEFT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
Latency(msec) Mean S.D Mean S.D 
Lat 1-3 1.74 0.58 2.04 0.43 
Lat 1-5 3.66 0.47 4.12 0.34 
Lat 3-5 1.91 0.48 1.93 0.44 
 
 The   comparison of   inter peak latencies between control and migraine  
patients in left ear  
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FIG: 10 INTERPEAK LATENCY IN LEFT EAR 
 
 
 
 Figure 10. shows interpeak latency(I-III,I-V,III-V) in left ear.The graph 
shows the mean interpeak latency is prolonged in migraine compared to 
controls 
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TABLE :8 COMPARISON OF INTERPEAK LATENCY OF THE LEFT 
EAR. 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE 
PATIENTS 
n=30 
P VALUE 
Lat 1-3 1.74+0.58 2.04+0.43 0.029 
Lat 1-5 3.66+0.47 4.12+0.34 0.005 
Lat 3-5 1.91+0.48 1.93+0.44 0.904 
 
p≤0.05 is significant; p≤0.01 is highly significant; p≤0.001 very highly 
significant. 
 
 The  comparison of interpeak latencies between control and migraine  
patients showed highly statistical significance in interpeak latencies  I-III   and  
I-Vin left ear.  
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TABLE:9 BAEP LATENCY IN RIGHT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
Lat 1 1.48±0.28 1.65±0.22 
Lat 2 2.71± 0.23 2.87±0.26 
Lat 3 3.42± 0.18 3.78±0.45 
Lat 4 4.68±0.22 4.79±0.29 
Lat 5 5.49±0.37 5.92±0.32 
 
The mean latency of control group and migraine  patients shows 
statistical significance. Latencies are prolonged in  migraine patients when 
compared to control. 
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FIG:11  BAEP LATENCY IN RIGHT EAR 
 
 
 
 Fig.11 shows BAEP latency in Right ear.The graph shows mean 
latency of control and migraine cases. Latency is prolonged in migraine 
compared to controls 
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TABLE :10 COMPARISON OF BAEP  LATENCY IN RIGHT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
P  VALUE 
Lat 1 1.48± 0.28 1.65±0.22 0.011 
Lat 2 2.71±0.23 2.87± 0.26 0.016 
Lat 3 3.42±0.18 3.78± 0.45 0.006 
Lat 4 4.68± 0.22 4.79±0.29 0.081 
Lat 5 5.49± 0.37 5.92±0.32 0.001 
 
p≤0.05 is significant; p≤0.01 is highly significant; p≤0.001 very highly 
significant. 
 
  This table shows prolongation  of latency of left  ear  of  migraine 
patients compared to control group and this is statisticaly significant 
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TABLE:11 INTERPEAK LATENCY IN RIGHT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
Lat 1-3 2.03±0.36 2.42±0.68 
Lat 1-5 3.81±0.55 4.36±0.57 
Lat 3-5 2.07±0.37 2.15±0.57 
 
 Thecomparison of interpeak latencies between control and migraine 
patients showed statistical significancein right ear. 
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TABLE:12 COMPARISON OF INTERPEAK LATENCY RIGHT EAR 
 
PARAMETER 
CONTROL 
n=30 
MIGRAINE PATIENTS 
n=30 
P Value 
Lat 1-3 2.03 0.36 2.42 0.68 0.007 
Lat 1-5 3.81 0.55 4.36 0.57 0.000 
Lat 3-5 2.07 0.37 2.15 0.57 0.83 
 
p≤0.05 is significant; p≤0.01 is highly significant; p≤0.001 very highly 
significant. 
 
 The  comparison of interpeak I-III,I-V,III-V latencies between control 
and migraine  patients showed statistical significance in Right ear. Latency I-V 
(p≤0.001 ) is very highly significant. 
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FIG:12 INTERPEAK LATENCY IN RIGHT EAR 
 
 
 
 Fig 12 shows BAEP latency in Right ear.The graph shows mean  
interpeak latency of control and migraine cases. interpeak latency is prolonged 
in migraine compared to controls 
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DISCUSSION 
 
In the present study, Brainstem auditory Evoked Potential parameters 
were evaluated in migraine patients in order to find out whether cortex or 
brainstem is involved in migraine patients. 
Migraine can best be explained as a ‘Brain state’ in which the cellular 
and vascular functional changes occur at the same time due to dysfunction of 
subcortical structures, brainstem and diencephalic nuclei that modulate 
sensory inputs. These nuclei act as a ‘Migraine Mediator’ whose dysfunction 
will lead to abnormal perception and activation of Trigeminal Vascular 
System (TVS) which then activate the central structures. Thus, Migraine is 
mainly due to TVS activation generated within the brain without a peripheral 
sensory input. 
Migraine is the central sensory processing disorder; there is dysfunction 
of descending brainstem pain modulatory system. The hyperexcitability of the 
nociceptive circuitry downstream is responsible for this central sensitization in 
Migraine patients. 
 The study was done with 30 migraine patients  and 30 controls with 
NEUROPERFECT EMG-2000-BAER- Both the controls and the migraine 
patients were stimulated with click stimuli of intensity 70Db above normal 
hearing threshold at the rate of 10sec and 0.1 msec duration were presented 
monoaurally and  the other ear was masked monoaurally by white noise. 
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Results were interpreted with respect to the latency and interpeak latency of 
both ears and compared between the migraine and normal subjects. 
 In our study there was no statistically significant difference in age, sex  
& BMIbetween control and study group ruling out the confounding variables  
regarding  Biophysical profile.This study coincides with the study done by 
Stockard et al 1979 which states  that central auditory  conduction is largely 
independent    of subjects biophysical profile. 
Brain Stem Evoked Response Audiometry (BAEP) 
 In this study, there is significant prolongation of latencies (all latencies) 
and interpeaklatencies (I-III & I-V) of BAEP waves in migraine when 
compared with controls.  Wave I-III is generated by the auditory branch of 
cranial nerve VIII and lower part of brain and Wave IV & V generated by 
upper brain. 
 In the present study there is prolongation of latencies in both ears.lt is 
supported by previous studies done by   Kaushal et al who evaluated BAEP in 
25 Migraine patients. The results revealed prolongation in latencies   I, III & V 
latencies and interpeak latencies I-III & I-Vand it was stated that prolongation 
was due to involvement of brainstem structures as well as activation of 
brainstem in migraine patients. These results were in accordance with our 
present study. 
Interpeak latency I-V represents conduction from the proximal part of 
the eighth nerve through pons to the mid brain. In this study there is 
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significant prolongation of I-V interpeak latency observed in migraine patients 
compared with controls. 
Similarily Bayazit Y et al .,studied BAEP in 20 migraine patients and  
reported abnormal BAEP findings in seven patients with increased latency of 
waves I , III & V and the interpeak latency 1-5. They concluded that cochlear 
vestibular symptoms can be seen in migraine patients and is due to defective 
neurotransmitter signaling and cerebral bioelectrical dysrhythmia.  
(Schlake H.P.etal, 1990).concluded that in migraine patients (including 
basilarmigraine) peak latencies were pathologically delayed. Statistical 
analysis did not show any significant difference in regard to peak latencies and 
interpeak latencies between migraine patients and controls. 
Table6&8 shows the comparison of absolute latency & interpeak 
latency between migraine and control group for left earandthere is significant 
difference between absolute latencies of migraine and control groups. 
However no significant difference is observed between   migraine and control 
groups for III-V interpeak latencies (p>0.05). 
Table7&9 shows the comparison of absolute latency & interpeak 
latency between migraine and control group for right ear and there is 
significant difference between absolute latencies of migraine and control 
groups. Similarly significant results are obtained for interpeak latencies 
between migraine and study groups. 
However no significant difference is observed between migraine and 
control groups for III-V interpeak  latencies (p>0.05) 
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However, side differences of all peaks (except peak IV, VI) were 
significantly increased in migraine patients as compared to controls. Results 
indicated a slight butpermanent impairment of brainstem function in migraine. 
Kuritzky A et al, 1981observed plasma serotonin level are essentially 
decreased during migraine attacks. Latency parameters values follow the 
variations in the serotonin levels. 
The serotonergiccontrolsystem, a dualhormone-neurotransmitter with 
numerous types of receptors.Serotonin is known as one of the most 
importantneurotransmitters.In the brain serotonin regulates the vascular 
smooth muscle tone of meningeal blood vessels.This amine structured 
neurotransmitterlevel is influenced in migraine 
 A.F. Lipkins et al.reported sudden sensorineural hearing loss in a 
patient during migraine attacks. Functional neuroimaging studies in patients 
with migraine during pain attacks had shown the activation of brainstem. 
Interpeak latency III-V reflexes the conduction from the lower pons to 
the mid brain. There is no prolongation of interpeak latencies III-V significant 
between study and control group for III-V interpeak   latency. 
In this present study BAEP reports showed significant prolongation of 
interpeak latency of wave I-III &I-V but no prolongation is observed in the 
interpeak latency of wave III-V in migraine when compared with controls. 
This result is supported by previous studies done by Firat Y et al   who   
measured auditory brainstem responses in pediatric population during the 
period of an attack and asymptomatic period of migraine. There was 
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prolongation of wave V and I –V Interpeak latency in migraineurs. These 
changes were due to temporary loss of auditory brainstem function in  
patientsmigraine. These results were in accordance with our present study.                       
Laila EL Mosly et al., Evaluated the role of Migraine on standard of life 
in females and associated changes in evoked potentials. They measured BAEP 
in 30 Migraine patients and reported that there was prolongation of latency III- 
V and I-V & I-III interpeak latency due to hyperexcitability of the cerebral 
cortex but no significant change in 3-5interpeak latency both during an attack 
and in the interictal phase. These results were similar with our present study. 
Anil K Dash et al., studied audiovestibular functions in migraine 
patients with and without vertigo. BAEP results revealed that there was 
significant prolongation in latencies of wave I, III & IV and interpeak 
latencies I-III, III-V & I-V. This study concluded that BAEP abnormalities are 
the earliest indicator of imminent acoustic involvement in migraine subjects. 
These results were consistent with our present study. 
 Sherifa A Hamed, Amal Mohammed Elatter evaluated vestibular 
function in 58 patients with migraine both with and without aura and reported 
prolongation in wave   III ,latency and I-III, III-V & I-V interpeak latencies. 
This study suggests that in Migraine, there is permanent vestibular damage 
either peripheral or central vestibular pathways. Similar results were observed 
in our study. 
Yang Y, Li P, Ye HC -Explored personality test and BAEPs in 30 Migraine 
patients. They reported that the latencies of wave I, III &V and the Interpeak 
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latencies of 3-5 were prolonged and related this prolongation to brainstem 
dysfunction. Similar results were observed in our study. 
ZgorzalewiczM et al., 14 this study evaluated BAEP in children and 
adolescents with primary headaches. They reported significant prolongation in 
latencies of wave III in Migraine children when compared with TTH. 
Drake ME et al., measured BAEP in 50 common migraine cases. They 
found that there was significant prolongation of I –V and III-V interpeak 
latency in migraine patients. This study suggests that prolongation was due to 
dysfunction of brainstem centers and possibly related to endorphin or 
serotonin neurotransmission. Present study also shows that during an attack of 
migraine brainstem structures play an active role leading to prolongation of 
interpeak latencies which supports the’ Brainstem activation theory of 
migraine’. 14 
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CONCLUSION 
 
 Thirty migraine patients both male and female and  thirty age matched 
healthy controls attending Neurology outpatient department participated in the 
study during the attack of migraine. BAEP was done after obtaining ethical 
committee clearance and informed consent by using NEUROPERFECT EMG-
2000. 
From the present study the following conclusions are made 
· There is prolongation of latency I, III and V which is statistically 
significant waves generated from lower brain stem structures 
mediating defective neurotransmitter signaling 
· Prolongation of interpeak latency of I-III and I-V is also 
statistically significant and it reveals that the prolongation is due 
to involvement of upper brain stem structures causing 
bioelectrical dysrhythmia 
· Increase in all peaks during migraine attack follows   the 
variation   in serotonergic control system substantiating that 
brain stem structures play an active role during the attack of 
migraine. 
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· Prolongation of interpeak latency supports the imminent acoustic 
involvement and   brain stem activation theory of migraine. 
· BAER can be used as an effective non-invasive, reliable, and 
diagnostic technique and earliest indicator of impending auditory 
involvement in migraine patients making neurophysiological 
evaluation of the auditory pathway&early intervention even in 
migraine patients without aura. 
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SUMMARY 
 
This study was conducted to assess the brain stem auditory evoked 
potentials in migraine patients for a continuous period of 10 milliseconds 
during head ache period. 30 migraine patients both male and female and 30 
age matched healthy controls attending neurology outpatient department 
participated in the study. After obtaining ethical committee clearance and 
informed consent BAEP was done using NEUROPERFECT EMG-2000. The 
results were statistically analysed and tabulated for discussion. It was found 
that there is involvement of brain stem in migraine patients. 
Latencies I, II, III, IV, V were prolonged indicating defective brainstem 
neurotransmitter signaling. 
Interpeak latency I – V, I – III,  prolongation supported the serotonergic 
control system dysfunction taken for analysis. 
So study proves that there is involvement of brain stem structures 
during migraine attacks evidenced by the extension of interpeak latencies of 
waves in BAER 
This study does not compare the duration of the disease with the 
changes in the BAER and the quantification   of neurotransmitter signaling. 
BAER can be used as an effective non-invasive, reliable, and diagnostic 
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technique and an earliest indicator of impending auditory involvement in 
migraine patients enabling to intervene even before in migraine patients 
without aura                                                                                         
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PROFORMA FOR CONDUCTING THE STUDY ON BRAIN STEM 
AUDITORY EVOKED POTENTIAL CHANGES IN MIGRAINE 
PATIENTS 
 
1.  Name : 
2.  Age : 
3  Sex : 
4.  Address : 
5.  Duration of the disease : 
6.  Any other associated illness 
 (i)  History of diabetes mellitus : 
 (ii)  History of hypertension 
 (iii)  History of any ear disease : 
7.  History of drug intake 
8.  Family history : 
9.  General examination 
10.  Investigations 
 (i)  Rinne’s and Weber’s test : 
 (ii)  Pure tone audiometry 
 (iii)  Brain stem auditory evoked : 
Potential 
11.  Date of conduct of experiment : 
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MIDAS QUESTIONNAIRE 
 
INSTRUCTIONS:  
 
 Please answer the following questions about allheadaches you have had 
over the last 3 months. Write zero if you did not do theactivity in the last 3 
months. 
 
1.  On how many days in the last 3 months did you miss work or 
schoolbecause of your headache?.....................................................days 
 
2.  How many days in the last 3 months was your productivity at work or 
school reduced by half or more because of your headaches ( do not 
include days you counted in question 1 where you missed work or 
school)?.....................days 
 
3.  On how many days in the last 3 months did you not do household work 
because of your headaches?............................................................days. 
 
4.  How many days in the last 3 months was your productivity in 
householdwork reduced by half or more because of your headaches (do 
not includedays you counted in question 3 where you did not do 
householdwork)?...............days. 
 
5.  On how many days in the last 3 months did you miss family, social, or 
leisure activities because of your headaches?................................days. 
 
A.  On how many days in the last 3 months did you have a 
headache?(if aheadache lasted more than one day , counted each 
day)………..days 
89 
B.  On a scale of 0-10, on average how painful were these 
headaches?(Where 0 = no pain at all, and 10 = pain as bad as it 
can, be)…………. 
 
•  Migraine Disability Assessment Score 
 
•  (Questions 1-5 are used to calculate the MIDAS score) 
 
Grade 1- Minimal or infrequent Disability; 0-5 
Grade II –Mild or infrequent Disability; 6-10 
 Grade III- Moderate Disability: 11-20 
 Grade IV-Severe Disability :> 20 (Innovative Medical Research 1997) 
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MASTER SHEET 
BERA - CONTROL GROUP LATENCY (ms)  
 
      
LEFT RIGHT 
Sl. No. Age Gender Ht Wt BMI LT I Lt II Lt III Lt IV Lt V I-III I-V III-V RT I Rt II Rt III Rt IV Rt V I-III I-V III-V 
1 27 2 149 45 20 1.65 2.77 3.2 4.77 5.1 1.55 3.45 1.9 1.42 3.08 3.48 4.6 5.08 2.06 3.67 1.6 
2 28 2 156 60 24 1.42 2.9 3.1 4.98 5.21 1.68 3.79 2.11 1.43 3.02 3.4 4.9 5.44 1.98 4.02 2.04 
3 25 2 156 55 22 1.6 2.56 3.2 4.81 5.4 1.6 3.8 2.2 1.42 2.98 3.6 4.69 5.48 2.19 4.06 1.88 
4 32 2 155 62 25 1.69 2.5 3.1 5.06 4.3 1.41 2.61 1.2 1.4 2.73 3.94 4.29 6.15 2.52 4.73 2.21 
5 45 2 146 60 28 1.56 3.08 3.1 4.98 5.1 1.54 3.54 2 1.42 2.5 3.69 4.56 5.4 1.69 3.4 1.71 
6 24 2 159 56 22 1.42 2.5 3.2 4.73 5 1.78 3.58 1.8 1.42 3.02 3.4 4.73 6.21 2.19 4.79 2.81 
7 24 2 153 43 18 1.9 2.5 2.5 4.69 5.3 0.6 3.4 2.8 1.42 2.5 3.52 4.42 5.23 1.56 3.27 1.71 
8 20 2 148 58 26 1.2 2.3 3.5 4.81 5.23 2.3 4.03 1.73 1.42 2.98 3.6 4.5 5.23 1.6 3.23 1.63 
9 38 2 155 54 22 1.2 1.5 3.1 4.77 5.3 1.9 4.1 2.2 1.6 2.6 3.48 4.77 5.69 1.48 3.68 2.21 
10 28 2 150 50 22 1.65 1.2 3.2 4.98 5.22 1.55 3.57 2.02 1.42 2.5 3.48 4.56 5.21 1.67 3.4 1.73 
11 25 2 153 58 24 1.5 2.8 3.1 4.5 4.5 1.6 3 1.4 1.42 3.06 3.4 4.52 6.06 2.52 4.65 2.66 
12 33 2 156 62 25 1.3 2.56 3.35 4.9 5.2 2.05 3.9 1.85 1.42 2.85 3.4 4.9 5.21 2.9 3.56 1.81 
13 40 2 154 64 27 1.65 2.5 3.35 4.81 5.2 1.7 3.55 1.85 1.73 2.65 3.6 5.06 5.48 2.44 4.06 1.88 
14 38 2 160 60 23 0.3 2.5 3.4 4.5 4.7 3.1 4.4 1.3 1.42 2.5 3.4 4.52 6.06 2.52 4.65 2.66 
15 40 2 156 53 21 1 1.3 2.3 4.56 5.2 1.3 4.2 2.9 1.42 3.08 3.4 5.08 5.73 2.29 4.08 2.33 
16 41 2 159 56 22 1.3 2.5 3.2 4.73 4.5 1.9 3.2 1.3 1.77 2.6 3.1 4.72 6.21 2.19 4.72 3.11 
17 32 2 158 48 19 0.3 2.1 3.1 4.81 5.23 2.8 4.93 2.13 2 2.8 3.6 4.5 5.23 1.6 3.23 1.63 
18 20 2 162 58 22 1.65 2.1 3.35 4.97 5.21 1.7 3.56 1.86 1.5 2.77 3.2 4.56 5.21 1.67 3.4 2.01 
19 29 2 155 48 20 1.65 2.77 3.1 4.77 4.9 1.45 3.25 1.8 1.42 3.08 3.21 4.6 5.08 2.06 3.67 1.87 
20 35 2 158 50 19 1.56 2.1 3.1 4.95 4.5 1.54 2.94 1.4 2 2.7 3.4 4.58 5.42 1.69 3.41 2.02 
21 24 2 160 58 22 1.65 2.5 2 4.81 5.1 0.35 3.45 3.1 1.42 2.5 3.2 5.06 5.48 2.44 4.06 2.28 
22 44 2 150 57 25 1.5 2.56 3.35 4.9 5.1 1.85 3.6 1.75 1.42 2.7 3.2 4.9 5.21 2.29 3.56 2.01 
23 28 2 160 59 23 0.3 1.3 3.2 4.81 4.5 2.9 4.2 1.3 1.04 2.1 3.6 4.5 5.23 1.6 3.23 1.63 
24 35 2 156 58 23 1.42 2.5 3.2 4.73 5.2 1.78 3.78 2 1.42 2.77 3.5 4.72 6.21 2.19 4.72 2.71 
25 22 1 166 64 23 1.3 1.5 3.1 4.5 5.21 1.8 3.91 2.11 1.4 2.5 3.1 4.5 5.21 1.85 3.21 2.11 
26 31 1 164 65 24 1.3 1.5 3.1 4.81 5.1 1.8 3.8 2 2 2.73 3.2 4.5 5.15 1.81 3.15 1.95 
27 28 1 167 67 24 1.5 1.3 3.1 5.08 4.5 1.6 3 1.4 1.3 2.23 3.6 5.01 5.54 2.16 4.02 1.94 
28 25 1 167 68 24 1.3 2.5 3.6 4.56 5.21 2.3 3.91 1.61 1.2 2.32 3.65 4.53 5.23 1.81 3.45 1.58 
29 38 1 160 60 23 1.5 1.5 3.42 4.5 5.21 1.92 3.71 1.79 1.42 2.6 3.2 4.5 5.21 1.85 3.21 2.01 
30 37 1 165 56 20 1.3 2.77 2.2 5.07 4.8 0.9 3.5 2.6 1.42 2.8 3.1 5.01 5.53 2.15 4.02 2.43 
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BERA - MIGRAINE PATIENTS LATENCY (ms) 
      RIGHT LEFT 
Sl. No. Age Gender Ht Wt BMI Rt I Rt II Rt III Rt IV Rt V I-III I-V III-V Lt I Lt II Lt III Lt IV Lt V I-III I-V III-V 
1 25 2 156 53 23 1.42 2.77 4.32 4.8 5.95 2.9 4.29 1.63 1.9 2.8 4.3 5.1 5.87 2.4 3.97 1.57 
2 48 2 146 57 27 1.42 3.08 4.33 4.4 5.96 2.9 4.53 1.67 2.2 2.9 4.4 5 5.97 2.2 4.1 1.57 
3 35 2 159 63 25 1.42 3.08 3.55 4.45 5.9 3.03 4.48 2.35 1.9 2.99 4.5 5.2 5.8 2.6 3.9 1.3 
4 28 2 153 56 24 1.42 3.08 3.75 4.4 5.8 3 4.4 2.1 2.1 2.72 4 5.4 5.9 1.9 4.6 1.9 
5 20 2 155 50 20 2 3.08 4.22 4.8 5.8 2.8 4.23 1.45 2 3.1 4.1 5.1 6.1 2.1 4.1 2 
6 21 2 149 54 23 1.42 2.51 3.85 4.9 5.6 3.01 4.4 2 2 2.6 4.5 5 6.1 2.5 4.1 1.6 
7 50 2 157 55 22 1.96 2.77 3.8 4.8 5.7 2.3 4.3 2 2.9 2.9 4.2 5.3 5.8 1.3 2.9 1.6 
8 45 2 156 56 22 2 3.08 3.4 5.08 5.95 1.9 4.2 2.3 2.5 3.1 4.1 5.5 6.1 1.6 4.2 2 
9 38 2 150 66 29 1.42 2.52 3.6 4.69 5.8 1.5 4.6 3.1 2.3 3.1 4.2 5.4 5.9 1.9 3.6 1.7 
10 20 2 154 54 22 1.81 2.6 4.25 4.98 5.8 2.9 4.43 1.9 2 2.5 4.5 5.6 5.9 2.5 4 1.4 
11 26 2 156 56 22 1.42 3.08 3.85 5.08 5.52 2.4 5.8 3.4 2.1 3 4.6 5.3 6 2.5 4.2 1.4 
12 35 2 142 50 24 1.65 3.08 3.69 4.98 5.85 2.8 4.1 1.9 2.1 2.9 4.3 5.7 6.5 2.2 4.4 2.2 
13 45 2 150 55 24 1.42 2.85 3.5 4.8 5.81 1.8 5.1 3.3 2.3 3 3.5 5.2 6.3 1.2 4 2.8 
14 32 2 153 54 23 1.42 3.08 4.42 5.08 6.21 3.9 4.79 2 2 2.9 3.9 5.01 6.5 1.9 4.5 2.6 
15 50 2 148 60 27 1 2.56 3.77 4.81 6.3 2.1 4.1 2 2.2 2.8 4.1 5.8 6.1 1.9 4.1 2 
16 35 2 159 63 29 1.42 2.51 4.77 4.79 5.91 3.49 3.44 1.43 2.1 2.9 4.3 5 5.9 2.2 3.8 1.6 
17 45 2 150 55 24 2 3.08 3.7 4.56 5.91 1.3 3.3 2 2.1 3.1 3.9 5.1 6.3 1.8 4.2 2.4 
18 32 2 153 54 23 1.81 2.6 4.8 4.9 6.2 3.3 4.7 1.4 2 2.5 4.5 5.3 6.1 2.5 4.3 1.6 
19 50 2 148 60 27 1.42 2.77 3.7 4.7 5.9 1.7 4.2 2.5 2.1 2.9 4.7 4.3 5.9 2.6 4 1.2 
20 35 2 159 63 25 2 3.08 3.3 4.5 5.5 1.6 4.4 2.8 2.2 2.3 4.1 5.4 6.4 1.9 4.4 2.3 
21 46 2 158 58 24 1.42 2.85 3.35 5.08 6.2 1.93 4.78 2.8 2.5 3.1 4.1 5 6.1 1.6 4.2 2 
22 21 2 147 56 25 1.65 3.08 3.85 5.08 6.2 2.5 4.4 1.9 2.5 1.6 3.5 5.2 6.1 1 3.9 2.6 
23 22 2 153 55 23 2 3.08 3.8 5.08 6.1 2.76 4.96 2.3 2.4 2.2 4.2 5.5 6.7 1.8 4.3 2.5 
24 40 2 150 58 25 1.42 2.51 3.08 5.08 5.75 2 4.6 2.6 2.3 3.8 4.1 5.5 6.8 1.8 4.5 2.7 
25 20 2 155 45 18 2 3.08 3.81 4.98 5.81 2.1 4.2 2.1 2.3 2.3 4.6 5.2 6.9 2.3 4.6 2.3 
26 23 2 155 53 21 2 3.06 3.3 4.5 6.2 1.1 2.8 1.7 2 1.9 4.6 5.1 6.1 2.6 4.3 1.5 
27 35 2 158 56 22 1.72 2.77 3.1 4.2 5.9 1.9 3.8 1.9 2 3.1 4.1 5.8 6.1 2.1 4.1 2 
28 34 2 156 51 20 1.79 2.5 3.08 4.1 5.9 2.5 4.9 2.4 2.4 2.9 4.1 5.3 6 1.7 4.2 1.9 
29 42 1 165 63 23 2 3.08 3.8 5.1 6.2 3.2 3.9 0.9 1.8 2.3 4.3 4.5 5.9 2.5 4.1 1.6 
30 23 1 160 68 27 1.71 2.77 3.75 5.1 6.4 2.2 4.8 2.6 2.1 2.8 4.1 4.7 6.1 2 4.3 2 
 
